Fragile X Syndrome Genetic Testing Market, Global Outlook and Forecast 2022-2028

January 2022 | 61 pages | ID: FA0876A7CE91EN
Market Monitor Global

Abstracts

Mangiferin, also known as Wanzhimuning. Light gray-yellow needle-like crystals (50% ethanol). It has good curative effect for the treatment of chronic bronchitis. It is the main active ingredient of Tibetan medicine Chen for treating hepatitis and the antiviral active ingredient in the rhizome of Zhimu.

This report contains market size and forecasts of Mangiferin in global, including the following market information:

Global Mangiferin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Mangiferin Market Sales, 2017-2022, 2023-2028, (Kiloton)

Global top five Mangiferin companies in 2021 (%)

The global Mangiferin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Purity>99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mangiferin include Merck, Macklin, Yuanye, Cayman Chemical, Chemscene, ALB Technology, Bio-Connect, Toronto Research Chemical and TCI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mangiferin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mangiferin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Mangiferin Market Segment Percentages, by Type, 2021 (%)

• Purity>99%
• Purity<99%

Global Mangiferin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Mangiferin Market Segment Percentages, by Application, 2021 (%)

• Antiviral
• Antitumor
• Protect Nerves
• Others

Global Mangiferin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Mangiferin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mangiferin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Mangiferin revenues share in global market, 2021 (%)

Key companies Mangiferin sales in global market, 2017-2022 (Estimated), (Kiloton)

Key companies Mangiferin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Macklin
• Yuanye
• Cayman Chemical
• Chemscene
• ALB Technology
• Bio-Connect
• Toronto Research Chemical
• TCI
• Carbosynth
• INDOFINE Chemical Company

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Fragile X Syndrome Genetic Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Fragile X Syndrome Genetic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FRAGILE X SYNDROME GENETIC TESTING OVERALL MARKET SIZE

2.1 Global Fragile X Syndrome Genetic Testing Market Size: 2021 VS 2028
2.2 Global Fragile X Syndrome Genetic Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Fragile X Syndrome Genetic Testing Players in Global Market
3.2 Top Global Fragile X Syndrome Genetic Testing Companies Ranked by Revenue
3.3 Global Fragile X Syndrome Genetic Testing Revenue by Companies
3.4 Top 3 and Top 5 Fragile X Syndrome Genetic Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Fragile X Syndrome Genetic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fragile X Syndrome Genetic Testing Players in Global Market
  3.6.1 List of Global Tier 1 Fragile X Syndrome Genetic Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Fragile X Syndrome Genetic Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Fragile X Syndrome Genetic Testing Market Size Markets, 2021 & 2028
  4.1.2 Genetic Screening
  4.1.3 Reproductive Genetic Testing
  4.1.4 Diagnostic Test
  4.1.5 Gene Carrier Test
  4.1.6 Testing Before Symptoms Appear
4.2 By Type - Global Fragile X Syndrome Genetic Testing Revenue & Forecasts
  4.2.1 By Type - Global Fragile X Syndrome Genetic Testing Revenue, 2017-2022
  4.2.2 By Type - Global Fragile X Syndrome Genetic Testing Revenue, 2023-2028
  4.2.3 By Type - Global Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Fragile X Syndrome Genetic Testing Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Diagnostic Center
5.2 By Application - Global Fragile X Syndrome Genetic Testing Revenue & Forecasts
  5.2.1 By Application - Global Fragile X Syndrome Genetic Testing Revenue, 2017-2022
  5.2.2 By Application - Global Fragile X Syndrome Genetic Testing Revenue, 2023-2028
  5.2.3 By Application - Global Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Fragile X Syndrome Genetic Testing Market Size, 2021 & 2028
6.2 By Region - Global Fragile X Syndrome Genetic Testing Revenue & Forecasts
  6.2.1 By Region - Global Fragile X Syndrome Genetic Testing Revenue, 2017-2022
  6.2.2 By Region - Global Fragile X Syndrome Genetic Testing Revenue, 2023-2028
  6.2.3 By Region - Global Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Fragile X Syndrome Genetic Testing Revenue, 2017-2028
  6.3.2 US Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.3.3 Canada Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.3.4 Mexico Fragile X Syndrome Genetic Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Fragile X Syndrome Genetic Testing Revenue, 2017-2028
  6.4.2 Germany Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.4.3 France Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.4.4 U.K. Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.4.5 Italy Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.4.6 Russia Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.4.8 Benelux Fragile X Syndrome Genetic Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Fragile X Syndrome Genetic Testing Revenue, 2017-2028
  6.5.2 China Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.5.3 Japan Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.5.4 South Korea Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.5.6 India Fragile X Syndrome Genetic Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Fragile X Syndrome Genetic Testing Revenue, 2017-2028
  6.6.2 Brazil Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.6.3 Argentina Fragile X Syndrome Genetic Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Fragile X Syndrome Genetic Testing Revenue, 2017-2028
  6.7.2 Turkey Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.7.3 Israel Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Fragile X Syndrome Genetic Testing Market Size, 2017-2028
  6.7.5 UAE Fragile X Syndrome Genetic Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Microread
  7.1.1 Microread Corporate Summary
  7.1.2 Microread Business Overview
  7.1.3 Microread Fragile X Syndrome Genetic Testing Major Product Offerings
  7.1.4 Microread Fragile X Syndrome Genetic Testing Revenue in Global Market (2017-2022)
  7.1.5 Microread Key News
7.2 Genecore
  7.2.1 Genecore Corporate Summary
  7.2.2 Genecore Business Overview
  7.2.3 Genecore Fragile X Syndrome Genetic Testing Major Product Offerings
  7.2.4 Genecore Fragile X Syndrome Genetic Testing Revenue in Global Market (2017-2022)
  7.2.5 Genecore Key News
7.3 Yin Feng Gene
  7.3.1 Yin Feng Gene Corporate Summary
  7.3.2 Yin Feng Gene Business Overview
  7.3.3 Yin Feng Gene Fragile X Syndrome Genetic Testing Major Product Offerings
  7.3.4 Yin Feng Gene Fragile X Syndrome Genetic Testing Revenue in Global Market (2017-2022)
  7.3.5 Yin Feng Gene Key News
7.4 Berrygenomics
  7.4.1 Berrygenomics Corporate Summary
  7.4.2 Berrygenomics Business Overview
  7.4.3 Berrygenomics Fragile X Syndrome Genetic Testing Major Product Offerings
  7.4.4 Berrygenomics Fragile X Syndrome Genetic Testing Revenue in Global Market (2017-2022)
  7.4.5 Berrygenomics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Fragile X Syndrome Genetic Testing Market Opportunities & Trends in Global Market
Table 2. Fragile X Syndrome Genetic Testing Market Drivers in Global Market
Table 3. Fragile X Syndrome Genetic Testing Market Restraints in Global Market
Table 4. Key Players of Fragile X Syndrome Genetic Testing in Global Market
Table 5. Top Fragile X Syndrome Genetic Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Fragile X Syndrome Genetic Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Fragile X Syndrome Genetic Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Fragile X Syndrome Genetic Testing Product Type
Table 9. List of Global Tier 1 Fragile X Syndrome Genetic Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fragile X Syndrome Genetic Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Fragile X Syndrome Genetic Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Fragile X Syndrome Genetic Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Fragile X Syndrome Genetic Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Fragile X Syndrome Genetic Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Fragile X Syndrome Genetic Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Fragile X Syndrome Genetic Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2023-2028
Table 30. Microread Corporate Summary
Table 31. Microread Fragile X Syndrome Genetic Testing Product Offerings
Table 32. Microread Fragile X Syndrome Genetic Testing Revenue (US$, Mn), (2017-2022)
Table 33. Genecore Corporate Summary
Table 34. Genecore Fragile X Syndrome Genetic Testing Product Offerings
Table 35. Genecore Fragile X Syndrome Genetic Testing Revenue (US$, Mn), (2017-2022)
Table 36. Yin Feng Gene Corporate Summary
Table 37. Yin Feng Gene Fragile X Syndrome Genetic Testing Product Offerings
Table 38. Yin Feng Gene Fragile X Syndrome Genetic Testing Revenue (US$, Mn), (2017-2022)
Table 39. Berrygenomics Corporate Summary
Table 40. Berrygenomics Fragile X Syndrome Genetic Testing Product Offerings
Table 41. Berrygenomics Fragile X Syndrome Genetic Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Fragile X Syndrome Genetic Testing Segment by Type in 2021
Figure 2. Fragile X Syndrome Genetic Testing Segment by Application in 2021
Figure 3. Global Fragile X Syndrome Genetic Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Fragile X Syndrome Genetic Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Fragile X Syndrome Genetic Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fragile X Syndrome Genetic Testing Revenue in 2021
Figure 8. By Type - Global Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028
Figure 12. US Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028
Figure 16. Germany Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028
Figure 24. China Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Fragile X Syndrome Genetic Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Fragile X Syndrome Genetic Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Microread Fragile X Syndrome Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Genecore Fragile X Syndrome Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Yin Feng Gene Fragile X Syndrome Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Berrygenomics Fragile X Syndrome Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)